Agios Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company. The Company's lead product candidate in its genetically defined disease (GDD) portfolio, mitapivat, is an activator for the treatment of hemolytic anemias. The Company’s clinic... اقرأ أكثر
euronews.com
skynewsarabia.com
skynewsarabia.com
skynewsarabia.com